Skip to content

BIOATLA, INC.

BCAB

CIK 0001826892

← back to feed
Revenue (TTM)
$0
Q1 Mar 2026
Net Income (TTM)
−$56.17M
+14.6% YoY Q1 Mar 2026
EPS Diluted (TTM)
−$17.97
+29.9% YoY Q1 Mar 2026
Gross Margin
—
Q1 Mar 2026
Operating Margin
—
Q1 Mar 2026
Net Margin
—
Q1 Mar 2026
Free Cash Flow (TTM)
—
Q1 Mar 2026
Cash
$1.96M
Q1 Mar 2026
Total Debt
—
Q1 Mar 2026
Shares Outstanding
32.32M sh
Q1 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings